pyridostigmine

(redirected from Mestinon SR)

pyridostigmine

 [pir″ĭ-do-stig´mēn]
an anticholinesterase; used as the bromide salt in the treatment of myasthenia gravis and as an antidote to nondepolarizing neuromuscular blocking agents such as tubocurarine.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

Mestinon

An oral agent used to manage myasthenia gravis.

Adverse effects
• Muscarinic—Nausea, vomiting, diarrhoea, abdominal cramps, increased peristalsis, increased salivation, increased bronchial secretions, miosis, diaphoresis; reversed with atropine.
• Nicotinic—Muscle cramps, fasciculation and weakness.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

pyridostigmine

Mestinon® Pharmacology A cholinergic used to manage Pts with myasthenia gravis, including crises Adverse effects ↑ salivation, fasciculation, abdominal cramps, diarrhea. See Reversal agent.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

pyridostigmine

A CHOLINERGIC drug used in the treatment of MYASTHENIA GRAVIS. The drug is on the WHO official list. A brand name is Mestinon.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005